Inhibitory effects of KHG26377 on glutamate dehydrogenase activity in cultured islets
2
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
GDH has been known to be related with hyperinsulinismhyperammonemia syndrome. We have screened new drugs with a view to developing effective drugs modulating GDH activity. In the present work, we investigated the effects of a new drug, KHG26377 on glutamate formation and GDH activity in cultured rat islets. When KHG26377 was added to the culture medium for 24 h prior to kinetic analysis, the Vmax of GDH was decreased by 59% whereas Km is not significantly changed. The concentration of glutamate decreased by 50%and perfusion of islets with KHG26377 reduced insulin release by up to 55%. Our results show that KHG26377 regulates insulin release by inhibiting GDH activity in primary cultured islets and support the previous studies for the connection between GDH activity and insulin release. Further studies are required to determine in vivo effects and pharmacokinetics of the drug.
Abstract
GDH has been known to be related with hyperinsulinismhyperammonemia syndrome. We have screened new drugs with a view to developing effective drugs modulating GDH activity. In the present work, we investigated the effects of a new drug, KHG26377 on glutamate formation and GDH activity in cultured rat islets. When KHG26377 was added to the culture medium for 24 h prior to kinetic analysis, the Vmax of GDH was decreased by 59% whereas Km is not significantly changed. The concentration of glutamate decreased by 50%and perfusion of islets with KHG26377 reduced insulin release by up to 55%. Our results show that KHG26377 regulates insulin release by inhibiting GDH activity in primary cultured islets and support the previous studies for the connection between GDH activity and insulin release. Further studies are required to determine in vivo effects and pharmacokinetics of the drug.
참고문헌 (26)
- Fisher, H. F., "L-Glutamate dehydrogenase from bovine liver", Methods Enzymol., 113, pp.16~27 (1985)
- Hudson, R. C., "L-Glutamate dehydrogenase: distribution, properties and mechanism", Comp. Biochem. Physiol. B., 106, pp.767~792 (1993)
- Nissim, I., "Newer aspects of glutamine", glutamate metabolism: the role of acute pH changes, 1999, pp.277, F493~F497
- Bryla, J., "Regulation of the glutamate dehydrogenase activity in rat islets of Langerhans and its consequence on insulin release", Metabolism, 43, pp.1187~1195 (1994)
- Yorifuji, T., "Hyperinsulinism-hyperammonemia syndrome caused by mutant glutamate dehydrogenase accompanied by novel enzyme kinetics", Hum. Genet., 104, pp.476~479 (1999)
- Carobbio, S., "Insulin secretion profiles are modified by overexpression of glutamate dehydrogenase in pancreatic islets", Diabetologia, 47, pp.266~276 (2004)
- Maechler, P., "Mitochondrial glutamate acts as a messenger in glucose-induced insulin exocytosis", Nature, 402, pp.685~689 (1999)
- Høy, M.H., "Increase in cellular glutamate levels stimulates exocytosis in pancreatic beta-cells", FEBS Lett., 531, pp.199~203 (2002)
- Haigis, M. C., "SIRT4 inhibits glutamate dehydrogenase and opposes the effects of calorie restriction in pancreatic beta cells", Cell, 126, pp.941~954 (2006)
- Ahuja, N., "Regulation of insulin secretion by SIRT4, a mitochondrial ADP-ribosyltransferase", J. Biol. Chem., 282, pp.33583~33592 (2007)
- Stanley, C. A., "Hyperinsulinism and hyperammonemia in infants with regulatory mutations of the glutamate dehydrogenase gene", N. Engl. J. Med., 338, pp.1352~1357 (1998)
- Stanley, C. A., "Molecular basis and characterization of the hyperinsulinism", hyperammonemia syndrome: predominance of mutations in exons 11 and 12 of the glutamate dehydrogenase gene. HI, Diabetes, pp.2000, 49[DOI]
- MacMullen, C., "Hyperinsulinism", hyperammonemia syndrome in children with regulatory mutations in the inhibitory guanosine triphosphate-binding domain of glutamate dehydrogenase, 2001, pp.86, 1782~1787
- Li, C., "Green tea polyphenols modulated insulin secretion by inhibition glutamate dehydrogenase", J. Biol. Chem., 281, pp.10214~10221 (2006)
- Yang, S. J., "Regulatory effects of 5'- deoxypyridoxal on glutamate dehydrogenase activity and insulin secretion in pancreatic islets", Biochimie, 85, pp.581~586 (2003)
- 조성우, "Inhibitory Effects of Cimicifuga heracleifolia Extract on Glutamate Formation and Glutamate Dehydrogenase Activity in Cultured Islets", 분자와 세포, 17(3), pp.509~514 (2004), 한국분자세포생물학회
- Li, M., "Novel inhibitors complexed with glutamate dehydrogenase", J. Biol. Chem., 284, pp.22988~23000 (2009)
- Kawaguchi, A., "Inhibition of glutamate dehydrogenase and malate dehydrogenases by palmitoyl coenzyme A", J. Biol. Chem., 251, pp.1406~1412 (1976)
- Fumagalli, E., "Riluzole enhances the activity of glutamate transporters GLAST, GLT1 and EAAC1", Eur. J. Pharmacol., 578, pp.171~176 (2008)
- Kulkarni, S. S., "Structure-activity relationships comparing N-(6-methylpyridin-yl)-substituted aryl amides to 2-methyl-6-(substitutedarylethynyl) pyridines or 2-methyl-4-(substituted-arylethynyl) thiazoles as novel metabotropic glutamate receptor subtype 5 antagonists", J. Med. Chem., 52, pp.3563~3575 (2009)
- -N-methylbenzamide as novel class of an orally active metabotropic glutamate receptor 1 (mGluR1) antagonist, "Bioorg. Med. Chem. Lett.", 2009, 5464~5468
- Choi, M. M., "Small-interfering-RNA-mediated silencing of human glutamate dehydrogenase induces apoptosis in neuroblastoma cells", Biotechnol. Appl. Biochem., 51, pp.107~110 (2008)
- Heinrikson, R. L., "Amino acid analysis by reverse-phase high-performance liquid chromatography: precolumn derivatization with phenylisothiocyanate", Anal. Biochem., 136, pp.65~74 (1984)
- Herbert, V., "Coated charcoal immunoassay of insulin", J. Clin. Endocrinol. Metab., 25, pp.1375~1384 (1965)
- Lee, E. Y., "Identification of GTP binding site of human glutamate dehydrogenase using cassette mutagenesis and photoaffinity labeling", J. Biol. Chem., 276, pp.47930~47936 (2001)
- Yoon, H. Y., "Importance of glutamate-279 for the coenzyme binding of human glutamate dehydrogenase", J. Biol. Chem., 277, pp.41448~41454 (2002)